Results 51 to 60 of about 51,398 (196)

Controversies in NEN: An ENETS position statement on nutritional support in neuroendocrine neoplasms

Journal of Neuroendocrinology, EarlyView.
Abstract Neuroendocrine neoplasms (NEN) themselves and also their treatment may cause malnutrition, inducing changes in physiological behaviour and eventually leading to increased rates of morbidity and mortality. Malnutrition is a common, under‐recognised and under‐treated condition in patients with NEN, and there are limited data available on the ...
Simona Grozinsky‐Glasberg, Johannes Hofland, Stephanie Alband, Yasmin Chotai de Lima, Adina Croitoru, Wanda Geilvoet, Peter Igaz, Beata Kos‐Kudła, Guenter J. Krejs, Alessandro Laviano, Francesco Panzuto, Anguraj Sadanandam, Ana Paula Santos, Staffan Welin, Rajaventhan Srirajaskanthan, V. Ambrosini, D. K. Bartsch, E. Baudin, N. Begum, E. Christ, J. Cros, T. Denecke, C. M. Deroose, C. Dromain, M. Falconi, N. Fazio, L. Fernandez‐Cuesta, R. Garcia‐Carbonero, A. Grossman, G. Kaltsas, A. Kasajima, A. Kjaer, G. Klöppel, U. P. Knigge, A. Lamarca, S. W. Langer, T. V. Luong, W. Martin, M. McNamara, D. O'Toole, S. Partelli, M. Pavel, A. Perren, R. Salazar, J. Schrader, H. Sorbye, A. Sowa‐Staszczak, E.‐J. Speel, P. Stalberg, M. Tesselaar, E. Tiensuu Janson, M. Tsoli, M. Volante, T. Walter   +53 more
wiley   +1 more source

Quadruple Valve Replacement for Carcinoid Heart Disease

Brazilian Journal of Cardiovascular Surgery
Introduction: Carcinoid heart disease most frequently involves the tricuspid or, more rarely, the pulmonary valve and presents with right heart failure as 5-HT is metabolized by the lung. Left-sided valve involvement is quite rare.
Syed Saleem Mujtaba, Stephen Clark
doaj   +1 more source

Oral paltusotine, a nonpeptide selective somatostatin receptor 2 agonist: Mass balance, absolute bioavailability and metabolism in healthy participants

British Journal of Clinical Pharmacology, Volume 91, Issue 7, Page 2070-2079, July 2025.
Abstract Aims Paltusotine is a novel, nonpeptide, selective somatostatin receptor 2 agonist in development for the treatment of acromegaly and carcinoid syndrome. This study investigated the mass balance, routes of excretion, absolute bioavailability and metabolite profile of orally administered paltusotine.
Rosa Luo, Ajay Madan, Christine T. Ferrara‐Cook, Deepak Dalvie, Lance Goulet, R. Scott Struthers, Alan S. Krasner   +6 more
wiley   +1 more source

Executive Summary of the American Radium Society Appropriate Use Criteria for the Management of Peritoneal Carcinomatosis From Different Tumor Origins: Systematic Review and Guidelines

Cancer Medicine, Volume 14, Issue 14, July 2025.
ABSTRACT Background Multimodality therapy incorporating a combination of cytoreductive surgery (CRS), intraperitoneal (IP) and systemic therapy continues to evolve for peritoneal carcinomatosis (PC) However, treatment and outcomes vary depending on tumor of origin.
Expert Panel Management of Peritoneal Carcinomatosis, Timothy Kennedy, Sareena Singh, Gerard Abood, Eric Christenson, Christopher J. Anker, Dmitriy Akselrod, Christopher L. Hallemeier, Krishan R. Jethwa, Ed Kim, Percy Lee, Eric D. Miller, Neil B. Newman, J. Eva Selfridge, Navesh Sharma, William Small Jr, Leila Tchelebi, Vonetta M. Williams, Suzanne Russo   +18 more
wiley   +1 more source

Malignant argentaffinoma and the carcinoid syndrome.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2000
No Abstract.
Krikler, Dennis M., Lackner, Henriette, Seally, Rossall   +2 more
openaire   +2 more sources

Predictors of Mortality in Patients With Multiple Endocrine Neoplasia Type 1

Clinical Endocrinology, Volume 103, Issue 1, Page 50-56, July 2025.
SUMMARY Objective Multiple Endocrine Neoplasia Type 1 (MEN 1) is an autosomal dominant disease predisposing to hyperplasia and neoplasia in diverse endocrine tissues. Patients typically present with endocrine abnormalities before the age of 30 years and have reduced life expectancy.
Jasmine J. Zhu, John R Burgess
wiley   +1 more source

Neuroendocrine tumors: Laboratory diagnosis [PDF]

Journal of Medical Biochemistry, 2010
Neuroendocrine tumors (NETs) are a heterogeneous group of neoplasms originating from endocrine cells, which are characterized by the presence of secretory granules as well as the ability to produce biogenic amines and polypeptide hormones.
Tzontcheva Anna
doaj  

Serotoninergic brain dysfunction in neuroendocrine tumor patients: A scoping review

Comprehensive Psychiatry, 2021
Introduction: Neuroendocrine tumors (NETs) are rare and malignant neoplasms characterized by their potential to produce metabolically active substances with the capacity to bring about clinical syndromes.
Anna La Salvia, Alberto Portigliatti Pomeri, Irene Persano, Elena Trevisi, Elena Parlagreco, Nicoletta Colombi, Maria Pia Brizzi, Rocco Luigi Picci, Francesco Oliva   +8 more
doaj  

Primary renal well‐differentiated neuroendocrine tumors with lymph node metastasis: A case report and literature review

IJU Case Reports, Volume 8, Issue 3, Page 202-205, May 2025.
Introduction Well‐differentiated neuroendocrine tumors of the kidney are rare and generally less aggressive than renal cell carcinoma, although metastasis is still present at the time of diagnosis. Surgical resection remains the preferred treatment, even in cases with lymph node metastases.
Huy‐Hoang Nguyen, Hoang‐Giang Phan, Duc‐Thuong Ho, Van‐Hung Le   +3 more
wiley   +1 more source

Cutaneous paraneoplastic syndromes. Dermatological manifestations associated with malignancies

Journal of Education, Health and Sport
Introduction and purpose: Paraneoplastic syndromes (PS) are conditions associated with malignant tumours whose mechanism of onset is not fully understood.
Paulina Polańska, Marta Gruszka, Martyna Zakrocka, Maria Kubicka   +3 more
doaj   +1 more source